These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6134016)

  • 1. Endralazine and sexual arousal.
    Zacest R; Reece PA
    Lancet; 1983 May; 1(8335):1221. PubMed ID: 6134016
    [No Abstract]   [Full Text] [Related]  

  • 2. Profile of a new vasodilator antihypertensive agent endralazine (BQ 22708).
    Oates HF
    Med J Aust; 1980 Apr; 1(8):393. PubMed ID: 7393091
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacologic effects of the antihypertensive 6-benzoyl-3-hydrazino-5,6,7,8-tetrahydropyrido[4,3-c]pyridazine (BQ 22-708, endralazine)].
    Salzmann R; Bürki H; Chu D; Clark B; Marbach P; Markstein R; Reinert H; Siegl H; Waite R
    Arzneimittelforschung; 1979; 29(12):1843-53. PubMed ID: 232662
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of food intake on plasma levels and antihypertensive response during maintenance therapy with endralazine.
    Kindler J; Rüegg PC; Neuray M; Pacha W
    Eur J Clin Pharmacol; 1987; 32(4):367-72. PubMed ID: 3609114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacological studies with the vasodilator endralazine in normotensive subjects and essential hypertensives.
    Elliott HL; Meredith PA; Howden CW; Lawrie CB; Reid JL
    Int J Clin Pharmacol Res; 1984; 4(1):61-9. PubMed ID: 6469433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-atherosclerotic and antihypertensive agents (XI)].
    Eguchi Y; Sugimoto A; Ito S; Nakajima M; Kaneko S; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1984; 18():17-23. PubMed ID: 6598493
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjects.
    Meredith PA; Elliott HL; McSharry DR; Kelman AW; Reid JL
    Br J Clin Pharmacol; 1983 Jul; 16(1):27-32. PubMed ID: 6882620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous endralazine in essential hypertension.
    Hoffmann JJ; Thien T; van T'Laar A
    Br J Clin Pharmacol; 1983 Jul; 16(1):39-44. PubMed ID: 6349669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endralazine, a new peripheral vasodilator: absence of effect of acetylator status on antihypertensive effect.
    Holmes DG; Bogers WA; Wideroe TE; Huunan-Seppala A; Wideroe B
    Lancet; 1983 Mar; 1(8326 Pt 1):670-1. PubMed ID: 6132036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-finding study of the combination of pindolol, clopamide and endralazine in the treatment of moderate-to-severe hypertension.
    Seedat YK; Rawat R
    S Afr Med J; 1984 Nov; 66(18):682-4. PubMed ID: 6387966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Search for pyridazine derivatives with hypotensive action].
    Bałoniak S; Drozdzyńska E; Linkowska E; Mroczkiewicz MF; Oledzka K; Zyczyńska-Bałoniak I
    Acta Pol Pharm; 1979; 36(3):295-300. PubMed ID: 517146
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of antihypertensive agents on sexual function.
    Weiss RJ
    Am Fam Physician; 1991 Dec; 44(6):2075-82. PubMed ID: 1684081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization and antihypertensive activity of pyridazinone derivatives.
    Siddiqui AA; Mishra R; Shaharyar M
    Eur J Med Chem; 2010 Jun; 45(6):2283-90. PubMed ID: 20189270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Antihypertensive activity of a new 3-hydrazinopyridazine derivative: ISF 2123.
    Carpi C; Dorigotti L
    Br J Pharmacol; 1974 Nov; 52(3):459P. PubMed ID: 4458870
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of multiple doses of ambrisentan on the pharmacokinetics of a single dose of digoxin in healthy volunteers.
    Richards DB; Spence R; Mandagere A; Henderson LS; Magee MH
    J Clin Pharmacol; 2011 Jan; 51(1):102-6. PubMed ID: 20350954
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical effects of GYKI-12 743.
    Bakonyi A; Tömösközi Z; Heiczman A; Horváth EJ; Arányi P; Rabloczky G
    Acta Physiol Hung; 1990; 75 Suppl():19-20. PubMed ID: 2164749
    [No Abstract]   [Full Text] [Related]  

  • 17. [Endralazine in the treatment of hypertension].
    Fet'kovská N; Tison P
    Vnitr Lek; 1984 Feb; 30(2):163-8. PubMed ID: 6372236
    [No Abstract]   [Full Text] [Related]  

  • 18. Triazolo- and tetrazolopyridazine derivatives and their hypotension and heart rate activity.
    Katrusiak A; Melzer E; Bałoniak S; Bobkiewicz T; Polcyn P
    Acta Pol Pharm; 2001; 58(3):217-23. PubMed ID: 11712740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marijuana and sexual activity.
    Koff WC
    J Sex Res; 1974 Aug; 10(3):194-204. PubMed ID: 4469012
    [No Abstract]   [Full Text] [Related]  

  • 20. [Female sexual dysfunction as adverse effect of pharmacological treatment].
    Giraldi AG; Victor J
    Ugeskr Laeger; 2002 Oct; 164(41):4757-60. PubMed ID: 12407875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.